The company announced today that it has acquired BioVision, Inc., a biopharmaceutical company based in Waltham, Massachusetts.  The company announced today that it had acquired BioVision in a multi-billion dollar acquisition.  According to the company's press release announcing the acquisition, BioVision's revenues increased by more than 200 percent in the first half of the year.  The company also announced that it would acquire BioVision in 2020.  According to the company's press release, BioVision's revenues increased by more than 400 percent in the first half of the year, and its revenue increased by more than 200 percent in the second half of the year.  The company's revenue increased by more than 400 percent in the second half of the year, and the company's adjusted operating profit increased by more than 300 percent.  The company's stock price rose more than 20 percent on the news.  The company's stock price also rose more than 20 percent.  The company's stock price increased by more than 300 percent on the news.  The company's revenue increased by nearly 400 percent in the second half of the year and the company's adjusted operating profit increased by nearly 300 percent.  The company's stock price increased more than 400 percent on the news.  The company's outlook for the second half of the year is positive.  The company's stock price increased by about 50 percent on the news.  The company's financial condition deteriorated significantly in the second half of the year.  According to the company's investor alert, the company's stock price rose more than 200 percent on the news.  The company's CEO, Diane Hirzel, and CFO, Alexis Baldock, both of whom I spoke to on the call, have agreed to the entry of a final judgment that permanently enjoins them from future violations of the antifraud provisions of Section 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder.  The settlement is subject to court approval.  The SEC's continuing investigation is being conducted by Tejas Sevant and Natalie Weston of the Boston Regional Office.  The SEC appreciates the assistance of the U.S. Attorney's Office for the District of Massachusetts, the Federal Bureau of Investigation, and the U.S. Secret Service.  The SEC's Office of Investor Education and Advocacy has issued anÂ Investor AlertÂ to encourage investors to check the background of anyone selling or offering them an investment using the free and simple search tool onÂ Investor.gov.